Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis
- PMID: 34376515
- DOI: 10.1136/gutjnl-2021-325214
Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis
Abstract
Objective: A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) is recommended for irritable bowel syndrome (IBS), if general lifestyle and dietary advice fails. However, although the impact of a low FODMAP diet on individual IBS symptoms has been examined in some randomised controlled trials (RCTs), there has been no recent systematic assessment, and individual trials have studied numerous alternative or control interventions, meaning the best comparator is unclear. We performed a network meta-analysis addressing these uncertainties.
Design: We searched the medical literature through to 2 April 2021 to identify RCTs of a low FODMAP diet in IBS. Efficacy was judged using dichotomous assessment of improvement in global IBS symptoms or improvement in individual IBS symptoms, including abdominal pain, abdominal bloating or distension, and bowel habit. Data were pooled using a random effects model, with efficacy reported as pooled relative risks (RRs) with 95% CIs, and interventions ranked according to their P-score.
Results: We identified 13 eligible RCTs (944 patients). Based on failure to achieve an improvement in global IBS symptoms, a low FODMAP diet ranked first vs habitual diet (RR of symptoms not improving=0.67; 95% CI 0.48 to 0.91, P-score=0.99), and was superior to all other interventions. Low FODMAP diet ranked first for abdominal pain severity, abdominal bloating or distension severity and bowel habit, although for the latter it was not superior to any other intervention. A low FODMAP diet was superior to British Dietetic Association (BDA)/National Institute for Health and Care Excellence (NICE) dietary advice for abdominal bloating or distension (RR=0.72; 95% CI 0.55 to 0.94). BDA/NICE dietary advice was not superior to any other intervention in any analysis.
Conclusion: In a network analysis, low FODMAP diet ranked first for all endpoints studied. However, most trials were based in secondary or tertiary care and did not study effects of FODMAP reintroduction and personalisation on symptoms.
Keywords: diet; irritable bowel syndrome; meta-analysis.
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome.Am J Gastroenterol. 2018 Sep;113(9):1290-1300. doi: 10.1038/s41395-018-0195-4. Epub 2018 Jul 26. Am J Gastroenterol. 2018. PMID: 30046155
-
Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis.Nutrients. 2017 Aug 26;9(9):940. doi: 10.3390/nu9090940. Nutrients. 2017. PMID: 28846594 Free PMC article. Review.
-
Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.PLoS One. 2017 Aug 14;12(8):e0182942. doi: 10.1371/journal.pone.0182942. eCollection 2017. PLoS One. 2017. PMID: 28806407 Free PMC article.
-
A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.Am J Gastroenterol. 2016 Dec;111(12):1824-1832. doi: 10.1038/ajg.2016.434. Epub 2016 Oct 11. Am J Gastroenterol. 2016. PMID: 27725652 Clinical Trial.
-
Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis.Eur J Nutr. 2016 Apr;55(3):897-906. doi: 10.1007/s00394-015-0922-1. Epub 2015 May 17. Eur J Nutr. 2016. PMID: 25982757 Review.
Cited by
-
Causative Factors, Clinical Manifestations, and Therapeutic Strategies for Irritable Bowel Syndrome.Cureus. 2024 Apr 22;16(4):e58728. doi: 10.7759/cureus.58728. eCollection 2024 Apr. Cureus. 2024. PMID: 38779277 Free PMC article. Review.
-
Can diet change the natural history of gastrointestinal diseases?JGH Open. 2024 May 20;8(5):e13063. doi: 10.1002/jgh3.13063. eCollection 2024 May. JGH Open. 2024. PMID: 38770354 Free PMC article. Review.
-
Evolution, adaptation, and new applications of the FODMAP diet.JGH Open. 2024 May 20;8(5):e13066. doi: 10.1002/jgh3.13066. eCollection 2024 May. JGH Open. 2024. PMID: 38770353 Free PMC article. Review.
-
Global research trend and hotspot in the low FODMAP diet: a bibliometric analysis.J Health Popul Nutr. 2024 May 13;43(1):63. doi: 10.1186/s41043-024-00567-7. J Health Popul Nutr. 2024. PMID: 38741213 Free PMC article.
-
The influence of the gut-brain axis on anxiety and depression: A review of the literature on the use of probiotics.J Tradit Complement Med. 2024 Mar 21;14(3):237-255. doi: 10.1016/j.jtcme.2024.03.011. eCollection 2024 May. J Tradit Complement Med. 2024. PMID: 38707924 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous